Brazilian CDMO IdeeLab unpacks the necessary steps for taking ag biologicals from molecules to markets around the world.

Market OutlookThe global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10 ...

Millions of myelin-producing cells have been mapped in the mouse brain, advancing our understanding of nervous system ...

The occasions for meeting him have been that he’s working on yet another totally ridiculous, batsh-t project that most people who have fronted the biggest franchise of a generation wouldn’t dabble in.

The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

In a wide-ranging interview with Vanity Fair, the US ambassador to Israel explained his controversial comments to Tucker Carlson and addressed a shift in public opinion against Israel over its bloody ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript February 26, 2026 BioLife Solutions, Inc. beats ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...

February 27, 2026 expert reaction to study looking at vegetarian and other diets and incidences of different cancers . A study published in the British Journal of Cancer looks at ...

The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.